Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




$29 Billion In Vitro Diagnostics Market Seen for 2007

By HospiMedica staff writers
Posted on 13 Feb 2002
The in vitro diagnostics (IVD) market generated revenues of nearly US$20 billion in 2000 and is projected to surge to more than $29 billion by 2007, according to a new analysis from Frost & Sullivan entitled "World In Vitro Diagnostic Technologies Markets.”

In vitro diagnostics offer early, accurate diagnosis of diseases, but a lack of comprehensive laboratory automation has slowed the evolution of absolute efficiency, according to Frost and Sullivan's analysis. More...
While automation has made important progress in recent years, there is a strong, often-overlooked need for automation in laboratory specimen processing, prioritizing, and preparation. The workload in this part of the IVD system is often erratic, making it a difficult section to automate. As a result, operations may slow down and experience delays that interrupt the smooth flow necessary for overall efficiency. Eventually, this results in a bottleneck within the processing section, and this constriction may cause inefficiency within other parts of the IVD procedures.

"In order to improve laboratory efficiency, efforts should be made to develop at least a partially automated system for the processing section,” said Frost & Sullivan analyst Kelly Westfall. "Until a reliable system can be integrated in processing, facilities will not fully realize how effectively their current automated workstations are operating.”




Related Links:
Frost & Sullivan

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.